2024-510856-11-00已完成1 期
A study to learn more about how BAY3283142 moves into, through, and out of the body of healthy participants when taken together with atazanavir and to assess the proportion of BAY3283142 that reaches the blood when taken by mouth.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Bayer AG
- 入组人数
- 15
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Therapeutic Area Head
Scientific
Bayer AG
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A study to learn how BAY2927088 is taken up and handled by the body in healthy male participants2022-502771-38-00Bayer AG, Bayer AG8
已完成
1 期
A study to learn how PF-07817883 is taken up into the blood of healthy adults after taking tablets of study drug with varying ingredients2023-506442-24-00Pfizer Inc., Pfizer Inc.12
已完成
1 期
A study to learn how safe the study treatment BAY2701250 is, how it affects the body and how it moves into, through and out of the body in healthy male participants when a single amount is given as an injection into the vein (intravenous infusion) or under the skin (subcutaneous injection).2023-503368-18-00Bayer AG91
招募中
1 期
A Phase 1 Study of BGB-B3227 Alone and in Combination With Tislelizumab in Patients With Advanced or Metastatic Solid Tumors2024-514216-27-00Beigene Ltd.35
招募中
1 期
C5951001- A Phase 1 Study of PF-08046876 in Participants with Advanced Solid Tumors.2025-521729-33-00Pfizer Inc.70